Yoshinori Marunaka Selected Research

7- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptane

10/2008	Effect of inducible nitric oxide synthase on apoptosis in Candida-induced acute lung injury.
4/2007	A novel potent inhibitor of inducible nitric oxide synthase, ONO-1714, reduces hyperoxic lung injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinori Marunaka Research Topics

Disease

22	Neoplasms (Cancer) 01/2021 - 12/2006
12	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2006
9	Insulin Resistance 01/2021 - 03/2013
9	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2014
6	Diabetes Mellitus 10/2021 - 01/2014
4	Carcinogenesis 05/2021 - 09/2014
4	Hypertension (High Blood Pressure) 01/2016 - 03/2004
4	Lung Injury 10/2008 - 01/2007
3	Acidosis 01/2019 - 03/2013
3	Hyperglycemia 01/2019 - 01/2016
3	Pheochromocytoma 01/2017 - 08/2007
3	Ascites 01/2014 - 12/2006
3	Lung Diseases (Lung Disease) 03/2009 - 05/2006
3	Acute Lung Injury 10/2008 - 02/2005
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 02/2018
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 05/2015 - 02/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2009 - 12/2006
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2009 - 05/2007
2	Hyperoxia 04/2007 - 01/2007
2	Hypoxia (Hypoxemia) 04/2007 - 06/2006
2	Edema (Dropsy) 12/2006 - 02/2005
2	Body Weight (Weight, Body) 03/2006 - 05/2002
1	Cognitive Dysfunction 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Neoplasm Metastasis (Metastasis) 11/2017
1	Liver Neoplasms (Liver Cancer) 05/2017
1	Substance-Related Disorders (Drug Abuse) 01/2017
1	Osteosarcoma (Osteogenic Sarcoma) 07/2016

Drug/Important Bio-Agent (IBA)

6	Insulin (Novolin)FDA Link 01/2021 - 05/2002
6	BuffersIBA 01/2019 - 01/2014
6	ChloridesIBA 06/2014 - 02/2008
5	AcidsIBA 01/2021 - 11/2013
5	Proteins (Proteins, Gene)FDA Link 10/2019 - 03/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2002
5	SaltsIBA 10/2018 - 03/2004
4	AnionsIBA 01/2021 - 04/2007
4	Oxygen (Dioxygen)IBA 01/2019 - 02/2005
4	SolutionsIBA 05/2017 - 08/2012
3	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2021 - 09/2014
3	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 09/2014
3	Sodium-Hydrogen ExchangersIBA 01/2021 - 01/2012
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2019 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 04/2007
3	RNA (Ribonucleic Acid)IBA 07/2016 - 03/2006
3	Expectorants (Mucolytics)IBA 03/2009 - 05/2006
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2008 - 04/2007
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2008 - 04/2007
3	Messenger RNA (mRNA)IBA 10/2007 - 03/2004
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2019
2	FlavonoidsIBA 08/2021 - 03/2004
2	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2021 - 01/2018
2	Superoxide DismutaseIBA 05/2021 - 04/2007
2	Ion Channels (Ion Channel)IBA 01/2021 - 09/2014
2	Aquaporins (Water Channels)IBA 01/2021 - 01/2016
2	Proton Pump InhibitorsIBA 11/2020 - 01/2019
2	Small Interfering RNA (siRNA)IBA 11/2019 - 10/2019
2	Adenosine Triphosphate (ATP)IBA 10/2018 - 06/2006
2	QuercetinIBA 01/2018 - 03/2004
2	Protein Isoforms (Isoforms)IBA 01/2018 - 08/2007
2	Propolis (Bee Bread)IBA 05/2015 - 03/2013
2	K Cl- CotransportersIBA 01/2014 - 11/2013
2	Nerve Growth Factor (NGF)IBA 01/2012 - 08/2007
2	Furosemide (Lasix)FDA LinkGeneric 08/2011 - 12/2006
2	Cisplatin (Platino)FDA LinkGeneric 12/2009 - 12/2006
2	Ambroxol (Mucosolvan)IBA 03/2009 - 05/2006
2	Pharmaceutical PreparationsIBA 03/2009 - 02/2005
2	7- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA 10/2008 - 04/2007
2	CytokinesIBA 04/2007 - 01/2007
1	AdrenomedullinIBA 01/2022
1	CateninsIBA 11/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2019
1	carboxyl radical (COO-)IBA 10/2018
1	Aquaporin 1IBA 07/2018
1	Death Domain ReceptorsIBA 07/2018
1	Chloride-Bicarbonate AntiportersIBA 05/2018
1	rat CLIC1 proteinIBA 05/2018
1	tranilastIBA 02/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2018
1	ninjin'yoeitoIBA 01/2018
1	CholesterolIBA 01/2018
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 11/2017
1	Hypotonic SolutionsIBA 11/2017
1	PotassiumIBA 11/2017
1	Aquaporin 5IBA 05/2017
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 03/2017
1	GTP Phosphohydrolases (GTPases)IBA 01/2017
1	GhrelinIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	TubulinIBA 01/2017
1	silicon nitrideIBA 07/2016
1	NitrogenIBA 07/2016

Therapy/Procedure

9	Therapeutics 01/2021 - 04/2007
7	Esophagectomy 10/2019 - 06/2014